SWITCH: An open-label prospective study of switching from pramipexole to ropinirole in RLS

被引：0
|
作者：
Mehta, S. H.
Iyer, S. S.
Bogan, R. K.
Jackson, P. D.
Prakash, R.
Prozonic, J.
Morgan, J. C.
Sethi, K. D.
机构：
来源：
MOVEMENT DISORDERS | 2009年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S443 / S444
页数：2
相关论文
共 50 条
  • [1] Switch from oral pramipexole or ropinirole to rotigotine transdermal system in advanced Parkinson's disease: an open-label study
    Chung, Sun Ju
    Kim, Jong-Min
    Kim, Jae Woo
    Jeon, Beom Seok
    Singh, Pritibha
    Thierfelder, Stephan
    Ikeda, Junji
    Bauer, Lars
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (07) : 961 - 970
  • [2] Open-Label Conversion Study of Pramipexole to Ropinirole Prolonged Release in Parkinson's Disease
    Lyons, Kelly E.
    Pahwa, Rajesh
    MOVEMENT DISORDERS, 2009, 24 (14) : 2121 - 2127
  • [3] An open-label conversion study of pramipexole to ropinirole prolonged release in patients with Parkinson's disease
    Pahwa, R.
    Lyons, K. E.
    MOVEMENT DISORDERS, 2008, 23 (01) : S314 - S314
  • [4] Ropinirole for restless legs syndrome (RLS): An open-label and double blind placebo controlled study
    Freeman, A
    Rye, DB
    Bliwise, D
    Chakravorty, S
    Krulewicz, S
    Watts, RL
    NEUROLOGY, 2001, 56 (08) : A5 - A5
  • [5] An open-label study on switching therapy from pramipexole or ropinirole to rotigotine transdermal system in subjects with advanced-stage, idiopathic Parkinson's disease
    Kim, J. M.
    Chung, S. J.
    Kim, J. W.
    Jeon, B. S.
    Bauer, L.
    Thierfelder, S.
    MOVEMENT DISORDERS, 2013, 28 : S175 - S175
  • [6] Open label comparative study on the efficacy of pramipexole (PMX) vs. ropinirole (RPN) for the treatment of restless legs syndrome (RLS)
    Galvez-Jimenez, N
    Lampuri, C
    Locker, GA
    Hanson, MR
    Smolley, L
    Hargreave, MJ
    MOVEMENT DISORDERS, 2002, 17 : S333 - S333
  • [7] Tolerability and efficacy of ropinirole in patients with intermittent restless legs syndrome (RLS): Open-label results
    Black, J.
    Merchant, K.
    MOVEMENT DISORDERS, 2006, 21 (09) : 1554 - 1554
  • [8] An open-label study on adding rotigotine treatment to low dose of pramipexole or ropinirole in patients with advanced Parkinson's disease
    Kim, J. M.
    Chung, S. J.
    Kim, J. W.
    Thierfelder, S.
    Bauer, L.
    Jeon, B. S.
    MOVEMENT DISORDERS, 2013, 28 : S220 - S220
  • [9] Switching from Remicade® to Remsima® is well Tolerated and Feasible: A Prospective, Open-label Study
    Buer, Lydia C. T.
    Moum, Bjorn A.
    Cvancarova, Milada
    Warren, David J.
    Medhus, Asle W.
    Hoivik, Marte Lie
    JOURNAL OF CROHNS & COLITIS, 2017, 11 (03): : 297 - 304
  • [10] An open-label, prospective, exploratory study of patients with epilepsy switching from levetiracetam to brivaracetam
    Yates, Stephen L.
    Fakhoury, Toufic
    Liang, Wei
    Eckhardt, Klaus
    Borghs, Simon
    D'Souza, Joseph
    EPILEPSY & BEHAVIOR, 2015, 52 : 165 - 168
12345